Serial #97533023
LIVE

Serial Number

97533023

Owner

Insilico Medicine IP Limited

Attorney

GREGORY J. CHINLUND

Filing Date

Aug 3, 2022

Add to watchlist:

No watchlists yet
View on USPTO

Serial #97533023 Trademark

Serial Number: 97533023 • Registration: 7377226

Serial #97533023 is a trademark filed by Insilico Medicine IP Limited on August 3, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Insilico Medicine IP Limited (20 trademarks)

Three Exchange Square, 8 Connaught Place
Central , HK

Entity Type: 77

Trademark Details

Filing Date

August 3, 2022

Registration Date

May 7, 2024

Published for Opposition

February 20, 2024

Goods & Services

Downloadable mobile applications using artificial intelligence for automated machine learning in the field of drug design and development; recorded computer software platforms using artificial intelligence for automated machine learning in the field of drug design and development; recorded computer software using artificial intelligence for automated machine learning in the field of drug design and development; downloadable computer programs using artificial intelligence for automated machine learning in the field of drug design and development; recorded computer programs using artificial intelligence for automated machine learning in the field of drug design and development; computer operating programs, recorded; data processing apparatus being data processors; Electronic card readers; data processing equipment, namely, scanners; Downloadable computer software using artificial intelligence for machine learning in the field of drug design and development; Downloadable data sets using artificial intelligence for automated machine learning in the field of drug design and development; Data sets using artificial intelligence for automated machine learning in the field of drug design and development recorded on computer media; all of the above in relation to biotechnology, pharmaceutical research and development, drug discovery and development, clinical trials and analysis

Pharmaceutical preparations for the treatment of fibrosis, oncology, immunology, anti-infectious, central nervous system related and other diseases and disorders; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Biological preparations for the treatment of cancer for medical purposes; Chemical preparations for pharmaceutical or medical purposes, namely, for treating fibrosis, oncology, immunology, anti-infectious, central nervous system related and other diseases and disorders; diagnostic preparations for medical purposes; dietary supplements for human beings; Dietetic foods and beverages adapted for medical use; adjuvants for medical purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Medicinal preparations for the mouth to be applied in the form of capsules; Pharmaceutical and biological preparations for the treatment of fibrosis, oncology, immunology, anti-infectious, central nervous system related and other diseases and disorders and cancer for medical purposes

Compilation of information into computer databases; compilation of statistics; computerized database management of medical data and files; office functions in the nature of searching for data in computer files for others; data processing services; wholesale distributorships featuring for medical supplies; retail store services featuring medical supplies; retail and wholesale store services for pharmaceutical preparations; retail and wholesale stores services for medical diagnostic preparations; updating and maintenance of data in computer databases; retail and wholesale store services for medical supplies for diagnostic purposes; data search in computer files for others being office functions in the nature of searching for data in computer files for others

Provision of scientific research information; Drug discovery research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development; product research and development in the field of biotechnology, molecular biology, pharmaceutics, oncology, immunology, biology and chemistry; Scientific and technological services, namely, scientific research and analysis in the field of pharmaceutical drugs and product research and design relating thereto; artificial intelligence driven robotics drug discovery scientific laboratory services; design and development of computer software; Software as a service (SAAS) services featuring software for use in database management in the field of drug design and development; software development in the framework of software publishing; updating of computer software; Platform as a service (PAAS) featuring computer software platforms for use in database management in the field of drug design and development; development of computer platforms; computer system design; rental of computer software for using artificial intelligence for automated machine learning in the field of drug design and development; creating and designing website-based indexes of information in the field of drug design and development for others using information technology services; computer programming; maintenance of computer software; research and development of new products for others; scientific and technological research relating to patent mapping; scientific research; platform as a service (PaaS) featuring computer software platforms for use in database management for using artificial intelligence for automated machine learning in the field of drug design and development; research in the field of artificial intelligence; conversion of data or documents from physical to electronic media; conversion of computer programs and data, other than physical conversion; electronic data storage; computer programming service for data processing; providing medical and scientific research information; Providing a web site that gives computer users the ability to upload and share video-based scientific protocols and other scientific-based videos; provision of scientific information in the fields of pharmaceutical research and development, drug discovery and medical and scientific research; all of the above in relation to biotechnology, pharmaceutical research and development, drug discovery and development, clinical trials and analysis

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 7, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
May 7, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 4, 2024 NPUB
PUBLISHED FOR OPPOSITION
Feb 20, 2024 PUBO
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 1, 2024 NPUB
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 1, 2024 NONP
CASE RETURNED TO EXAMINATION
Jan 16, 2024 OTHE
NOTICE OF ALLOWANCE CANCELLED
Jan 16, 2024 IUCN
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Dec 8, 2023 JURT
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Dec 8, 2023 PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Dec 8, 2023 PCBG
ASSIGNED TO PETITION STAFF
Dec 7, 2023 APET
TEAS PETITION TO AMEND BASIS RECEIVED
Nov 13, 2023 TPAD
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Nov 9, 2023 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 9, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 9, 2023 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 9, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 9, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 9, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 9, 2023 COAR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 24, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 29, 2023 NPUB
PUBLISHED FOR OPPOSITION
Aug 29, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 9, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 24, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 20, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 20, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 20, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 20, 2023 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jul 6, 2023 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jul 4, 2023 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 16, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 13, 2023 XAEC
ASSIGNED TO LIE
Jun 13, 2023 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 7, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 7, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 7, 2023 CNEA
ASSIGNED TO EXAMINER
May 20, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 25, 2022 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 24, 2022 NWOS
NEW APPLICATION ENTERED
Aug 6, 2022 NWAP